Actively Recruiting
A Study to Evaluate the Efficacy and Safety of AD-224
Led by Addpharma Inc. · Updated on 2025-02-04
252
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of AD-224
CONDITIONS
Official Title
A Study to Evaluate the Efficacy and Safety of AD-224
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Patients with Essential Hypertension
- Other inclusions applied
You will not qualify if you...
- Patient with Secondary Hypertension
- Other exclusions applied
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Bundang Hospital
Seongnam-si, South Korea
Actively Recruiting
Research Team
J
JeongEun Park
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here